阿莱恩斯西部银行 WAL 深 沪
已收盘 10-10 16:00:00 美东时间
74.93
-4.600
-5.78%
华盛通- 最 高79.74
- 今 开79.74
- 成交量 296.73万股
- 最 低 74.605
- 昨 收 79.53
- 总市值 82.42亿
- 52周最高 96.955
- 市盈率 静 10.57
- 换手率 0.00%
- 52周最低 56.29
- 委 比 65.29%
- 总股本 1.10亿
- 历史最高 119.43
- 量 比 1.78
- 振 幅 6.46%
- 历史最低 -3.76
- 每 手 1
- 风险率 11.98%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Red flags at First Brands ignored by creditors
Auto-parts maker First Brands declared bankruptcy a couple of weeks ago and left investors and creditors with billions of dollars in potential losses, yet it remains unclear what exactly went wrong. W...
10-10 22:37
RBC Capital Maintains Outperform on Western Alliance, Raises Price Target to $100
RBC Capital analyst Jon G. Arfstrom maintains Western Alliance (NYSE:WAL) with a Outperform and raises the price target from $93 to $100.
10-10 21:39
商标之争再起，加多宝和王老吉大健康再打诉讼战
10月10日，加多宝集团发布声明，声称拥有王老吉海外商标所有权。而此前9月30日，广州王老吉大健康产业有限公司（下称“王老吉大健康公司”）则指责加多宝属于恶意抢...
10-10 19:21
WAL Token Now Listed on Binance Alpha and Spot Exchanges
Grand Cayman, Cayman Islands, October 10th, 2025, Chainwire Following a $140 mi...
10-10 16:00
Justice Department launches inquiry into First Brands bankruptcy
The U.S. Department of Justice has opened an inquiry into the collapse of First Brands, an auto supplier that filed for bankruptcy two weeks ago, as federal prosecutors map out how investors and credi...
10-10 04:08
Wallenstam Appoints Susann Linde as Vice CEO
Wallenstam AB ( ($SE:WALL.B) ) has shared an update. Wallenstam AB has appointe...
10-07 23:33
凯德腾飞房地产信托计划收购新加坡三处工业房地产
凯德腾飞房地产信托10月7日发布公告，计划以总收购价约5.658亿新元，购入在新加坡的三处房地产。交易预计明年第一季完成。 凯德腾飞房地产信托管理公司首席执行官...
10-07 12:00
Poonawalla Fincorp Updates Compliance Officer Details as per SEBI Regulations
Poonawalla Fincorp Limited ( ($IN:POONAWALLA) ) just unveiled an update. Poonaw...
10-03 15:14
美股大行评级 | 潜在涨幅162.68%！Ocular Therapeutix获JMP证券升目标价至29美元，维持"跑赢大市"评级
今日重点评级关注：JMP证券：维持Ocular Therapeutix"跑赢大市"评级，目标价从20美元升至29美元；汇丰银行：上调Banco BBVA Argentina评级至"买入"，目标价从21美元下调至17美元
10-02 15:08
美股大行评级 | 星展银行上调百度评级至"买入"，目标价177美元；多家机构上调Guardant Health(GH)目标价最高至80美元
今日重点评级关注：Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12美元升至12.5美元；Oppenheimer：维持Immuneering"跑赢大市"评级，目标价从21美元升至30美元
09-26 09:45
